Zimmer Biomet (ZBH) PT Lowered to $113 at Truist, Reflecting 'Below-CNS EPS Guide'
Tweet Send to a Friend
Truist Securities analyst Richard Newitter lowered the price target on Zimmer Biomet (NYSE: ZBH) to $113.00 (from $118.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
